Skip to Main Content

Medtronic plc

MDT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$MDT is featured in our Shelley Moore Capito and Dan Meuser strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDT by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Mar 30, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 23, 2026
Kevin Hern House / R Sale $15,001 - $50,000 Mar 20, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Mar 10, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 23, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jan 22, 2026
Julie Johnson House / D Sale $1,001 - $15,000 Dec 18, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Nov 13, 2025
Richard McCormick House / R Purchase $1,001 - $15,000 Nov 05, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 27, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 15, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
George Whitesides House / D Sale $50,001 - $100,000 Mar 24, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Mar 20, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 19, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Emily Randall House / D Sale $1,001 - $15,000 Jan 06, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Sale $1,001 - $15,000 N/A
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Aug 26, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jul 09, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun 18, 2024
John James House / R Sale $1,001 - $15,000 Jun 03, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 13, 2024
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb 09, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan 23, 2024
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Kathy E. Manning House / D Sale $15,001 - $50,000 Dec 12, 2023
Debbie Dingell House / D Purchase $15,001 - $50,000 Dec 05, 2023
John James House / R Purchase $1,001 - $15,000 Nov 10, 2023
MDT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MDT holdings by institutional investors

Quarterly net insider trading by MDT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

MDT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

MDT Revenue by Segment or Geography

By Segment
By Geography
MDT Income Statement
MDT Balance Sheet
MDT Cash Flow
U.S. Patents

New MDT patent grants

  • Patent Title: Method and apparatus for adjusting a threshold during atrial arrhythmia episode detection in an implantable medical device Apr. 10, 2018
  • Patent Title: Communications network for distributed sensing and therapy in biomedical applications Apr. 10, 2018
  • Patent Title: Fully inhibited dual chamber pacing mode Apr. 03, 2018
  • Patent Title: Transcatheter heart valve replacement systems, heart valve prostheses, and methods for percutaneous heart valve replacement Apr. 03, 2018
  • Patent Title: Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions Apr. 03, 2018
  • Patent Title: Minimally invasive implantable neurostimulation system Apr. 03, 2018
  • Patent Title: Systems, methods, and interfaces for identifying effective electrodes Apr. 03, 2018
  • Patent Title: Delivery systems and methods of implantation for prosthetic heart valves Mar. 27, 2018
  • Patent Title: Transcatheter valve with torsion spring fixation and related systems and methods Mar. 27, 2018
  • Patent Title: Power-efficient chopper amplifier Mar. 27, 2018
  • Patent Title: Rhythm discriminator with immunity to body posture Mar. 27, 2018
  • Patent Title: Systems, methods, and interfaces for identifying effective electrodes Mar. 27, 2018
  • Patent Title: Programming posture responsive therapy Mar. 20, 2018
  • Patent Title: Configuring operating parameters of a medical device based on exposure to a disruptive energy field Mar. 20, 2018
  • Patent Title: Connector assemblies for receiving implantable medical leads Mar. 20, 2018
  • Patent Title: Ultralow-power implantable hub-based wireless implantable sensor communication Mar. 20, 2018
  • Patent Title: Managing telemetry communication modes of an implantable device Mar. 13, 2018
  • Patent Title: Systems, apparatus, methods and computer-readable storage media facilitating telemetry with an implantable device Mar. 13, 2018
  • Patent Title: Sinus-engaging valve fixation member Mar. 13, 2018
  • Patent Title: Error correction techniques in surgical navigation Mar. 13, 2018
  • Patent Title: Semi-solid electrolytes for batteries Mar. 06, 2018
  • Patent Title: Implantable medical devices with header structures including conductive paths that facilitate the interconnection of feedthrough conductors to electrical connectors Mar. 06, 2018
  • Patent Title: Medical devices including metallic connector enclosures Mar. 06, 2018
  • Patent Title: Arrhythmia prediction based on heart rate turbulence Mar. 06, 2018
  • Patent Title: Velocity detection for posture-responsive therapy Mar. 06, 2018
  • Patent Title: Paired medical lead bodies with braided conductive shields having different physical parameter values Mar. 06, 2018
  • Patent Title: Active fixation medical electrical lead Mar. 06, 2018
  • Patent Title: Elastic introducer sheath Mar. 06, 2018
  • Patent Title: Multi-electrode peripheral nerve evaluation lead and related system and method of use Mar. 06, 2018
  • Patent Title: Medical electrical lead Feb. 27, 2018
  • Patent Title: Medical electrical lead having improved inductance Feb. 27, 2018
  • Patent Title: Low profile instrument immobilizer Feb. 27, 2018
  • Patent Title: Monitoring conditions of an implantable medical fluid delivery device Feb. 27, 2018
  • Patent Title: Coordination of functional mri scanning and electrical stimulation therapy Feb. 27, 2018
  • Patent Title: Method and apparatus for identifying sick sinus syndrome in an implantable cardiac monitoring device Feb. 27, 2018
  • Patent Title: Distal connector assemblies for medical lead extensions Feb. 20, 2018
  • Patent Title: Charging process for lithium-ion batteries Feb. 20, 2018
  • Patent Title: Method for calculating an estimate of a time-varying physiological variable Feb. 20, 2018
  • Patent Title: Water management system for use in dialysis Feb. 20, 2018
  • Patent Title: Detachable module for recharging sorbent materials with optional bypass Feb. 20, 2018
  • Patent Title: Method and apparatus for detecting change in intrathoracic electrical impedance Feb. 20, 2018
  • Patent Title: Suture loop with cover and strategic placement of suture points Feb. 13, 2018
  • Patent Title: Far-field r-wave detection to control atrial pace timing in a dual-chamber leadless pacemaker Feb. 13, 2018
  • Patent Title: Infusion device assembly Feb. 13, 2018
  • Patent Title: Method and apparatus for detecting a biomarker in the presence of electrical stimulation Feb. 13, 2018
  • Patent Title: Parallel modules for in-line recharging of sorbents using alternate duty cycles Feb. 06, 2018
  • Patent Title: Sensing temperature within medical devices Jan. 30, 2018
  • Patent Title: Trial stimulation systems Jan. 30, 2018
  • Patent Title: Entrainment of bioelectrical brain signals Jan. 30, 2018
  • Patent Title: Anchors including rigid bodies defining full length slots for use with implantable medical leads Jan. 30, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to MDT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
MDT News

Recent insights relating to MDT

CNBC Recommendations

Recent picks made for MDT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDT

MDT Analyst Ratings

MDT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDT stock a Buy, Sell, or Hold?

  • What is the price target for $MDT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDT Top Shareholders
Shareholder
Shares Held
MDT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDT stock?

  • Who owns the most shares of $MDT stock?

  • What funds own $MDT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDT

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Medtronic plc Executive Compensation
Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation